Ann-Kathrin Wallisch
BioNTech (Germany)(DE)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, SARS-CoV-2 detection and testing, Viral gastroenteritis research and epidemiology, COVID-19 Clinical Research Studies
Most-Cited Works
- → Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera(2021)554 cited
- → Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera(2022)383 cited
- → Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes(2022)218 cited
- → A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates(2020)139 cited
- → Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera(2021)108 cited
- → Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5(2022)74 cited
- → Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice(2022)34 cited
- → Neutralization of SARS-CoV-2 Omicron pseudovirus by BNT162b2 vaccine-elicited human sera(2021)24 cited
- → BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2(2020)22 cited